SCHEMBL19081680

SCHEMBL19081680

CC1(C)c2ccccc2-c2ccc(-c3c4ccccc4c(-c4ccc5c(c4)oc4c5ccc5c4oc4ccc6ccccc6c45)c4ccccc34)cc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.32
ABCG2 Q9UNQ0 4/20 0.32
PRKDC P78527 1/20 0.32
PAX8 Q06710 2/20 0.32
NPC1 O15118 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
RAB9A P51151 1/20 0.32
MEN1 O00255 1/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP1A1 P04798 1/20 0.32
CYP1A2 P05177 1/20 0.32
FYN P06241 1/20 0.32
MAPK3 P27361 1/20 0.32
ARSA P15289 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127575 0.91 ABCG2 (0.35) AHRABCG2PAX8NPC1TDP1
SCHEMBL20127518 0.91 ARSA (0.36) ABCG2PRKDCTDP1TP53CYP3A4
SCHEMBL19081732 0.91 ABCG2 (0.33) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL19081679 0.90 ABCG2 (0.33) AHRABCG2PRKDCPAX8NPC1
SCHEMBL19081684 0.90 ABCB1 (0.33) ABCG2PRKDCTDP1CYP3A4CYP2C19
SCHEMBL19081672 0.89 ABCG2 (0.33) AHRABCG2PAX8NPC1TDP1
SCHEMBL19080959 0.89 ABCG2 (0.32) AHRABCG2PAX8NPC1TDP1
SCHEMBL20127525 0.88 ARSA (0.34) ABCG2PRKDCTDP1CYP3A4CYP2C19
SCHEMBL10122700 0.88 ABCG2 (0.34) AHRABCG2PAX8NPC1TDP1
SCHEMBL10122702 0.88 ABCG2 (0.34) AHRABCG2PAX8NPC1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 AHR 2453/4885ABCG2 4823/4885PRKDC 4719/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 AHR 2453/4885ABCG2 4823/4885PRKDC 4719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.